Primecap Management’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.74M Sell
299,718
-57,254
-16% -$1.48M 0.01% 270
2025
Q1
$3.64M Sell
356,972
-12,387
-3% -$126K ﹤0.01% 290
2024
Q4
$5.15M Sell
369,359
-24,805
-6% -$346K ﹤0.01% 273
2024
Q3
$7.69M Sell
394,164
-7,200
-2% -$140K 0.01% 272
2024
Q2
$7.47M Sell
401,364
-63,079
-14% -$1.17M 0.01% 267
2024
Q1
$6.51M Sell
464,443
-2,340
-0.5% -$32.8K ﹤0.01% 274
2023
Q4
$3.96M Sell
466,783
-13,083
-3% -$111K ﹤0.01% 292
2023
Q3
$4.29M Sell
479,866
-63,459
-12% -$567K ﹤0.01% 289
2023
Q2
$4.69M Sell
543,325
-222,210
-29% -$1.92M ﹤0.01% 286
2023
Q1
$8.07M Sell
765,535
-278,402
-27% -$2.94M 0.01% 262
2022
Q4
$35.4M Sell
1,043,937
-50,893
-5% -$1.73M 0.03% 183
2022
Q3
$52.6M Sell
1,094,830
-8,591
-0.8% -$412K 0.05% 171
2022
Q2
$62.9M Sell
1,103,421
-34,034
-3% -$1.94M 0.06% 162
2022
Q1
$92M Sell
1,137,455
-23,373
-2% -$1.89M 0.07% 158
2021
Q4
$235M Sell
1,160,828
-37,807
-3% -$7.66M 0.16% 109
2021
Q3
$323M Sell
1,198,635
-6,816
-0.6% -$1.84M 0.23% 93
2021
Q2
$310M Sell
1,205,451
-5,574
-0.5% -$1.43M 0.21% 94
2021
Q1
$363M Sell
1,211,025
-18,335
-1% -$5.5M 0.25% 87
2020
Q4
$313M Sell
1,229,360
-28,415
-2% -$7.25M 0.23% 91
2020
Q3
$313M Sell
1,257,775
-35,998
-3% -$8.96M 0.26% 82
2020
Q2
$449M Sell
1,293,773
-71,755
-5% -$24.9M 0.39% 64
2020
Q1
$366M Buy
1,365,528
+26,838
+2% +$7.19M 0.36% 66
2019
Q4
$433M Buy
1,338,690
+63,809
+5% +$20.7M 0.31% 76
2019
Q3
$348M Buy
1,274,881
+2,186
+0.2% +$597K 0.28% 86
2019
Q2
$679M Sell
1,272,695
-17,693
-1% -$9.44M 0.5% 58
2019
Q1
$650M Sell
1,290,388
-2,947
-0.2% -$1.49M 0.48% 60
2018
Q4
$638M Sell
1,293,335
-50,326
-4% -$24.8M 0.52% 56
2018
Q3
$1.23B Sell
1,343,661
-49,867
-4% -$45.6M 0.83% 39
2018
Q2
$1.02B Sell
1,393,528
-10,598
-0.8% -$7.76M 0.76% 41
2018
Q1
$2.24B Sell
1,404,126
-86,375
-6% -$138M 1.68% 18
2017
Q4
$1.34B Sell
1,490,501
-52,314
-3% -$46.9M 1.02% 28
2017
Q3
$555M Buy
1,542,815
+1,329
+0.1% +$478K 0.46% 58
2017
Q2
$452M Buy
1,541,486
+111,254
+8% +$32.6M 0.39% 66
2017
Q1
$504M Buy
1,430,232
+1,153
+0.1% +$406K 0.46% 60
2016
Q4
$263M Buy
1,429,079
+95,304
+7% +$17.5M 0.26% 81
2016
Q3
$344M Buy
1,333,775
+269
+0% +$69.3K 0.34% 70
2016
Q2
$285M Sell
1,333,506
-500
-0% -$107K 0.3% 75
2016
Q1
$275M Buy
1,334,006
+15,054
+1% +$3.1M 0.29% 77
2015
Q4
$333M Buy
1,318,952
+2,693
+0.2% +$681K 0.34% 70
2015
Q3
$216M Buy
1,316,259
+2,467
+0.2% +$406K 0.24% 86
2015
Q2
$247M Buy
1,313,792
+10,286
+0.8% +$1.93M 0.24% 92
2015
Q1
$215M Buy
1,303,506
+88,454
+7% +$14.6M 0.21% 95
2014
Q4
$283M Buy
1,215,052
+5,866
+0.5% +$1.36M 0.29% 79
2014
Q3
$219M Buy
1,209,186
+155,567
+15% +$28.2M 0.23% 88
2014
Q2
$203M Buy
1,053,619
+18,013
+2% +$3.46M 0.22% 90
2014
Q1
$188M Buy
1,035,606
+202,380
+24% +$36.8M 0.21% 93
2013
Q4
$142M Buy
833,226
+169,636
+26% +$28.9M 0.17% 101
2013
Q3
$104M Buy
663,590
+158,600
+31% +$24.8M 0.14% 110
2013
Q2
$87.5M Buy
+504,990
New +$87.5M 0.13% 110